These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 35777316)

  • 1. The brilliance of nanoscience over cancer therapy: Novel promising nanotechnology-based methods for eradicating glioblastoma.
    Shabani L; Abbasi M; Amini M; Amani AM; Vaez A
    J Neurol Sci; 2022 Sep; 440():120316. PubMed ID: 35777316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug delivery approaches for the treatment of glioblastoma multiforme.
    Fakhoury M
    Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1365-73. PubMed ID: 26046399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.
    Wiwatchaitawee K; Quarterman JC; Geary SM; Salem AK
    AAPS PharmSciTech; 2021 Feb; 22(2):71. PubMed ID: 33575970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of nanoparticles for drug delivery in glioblastoma multiforme.
    Jain KK
    Expert Rev Neurother; 2007 Apr; 7(4):363-72. PubMed ID: 17425491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment.
    Zhao C; Zhu X; Tan J; Mei C; Cai X; Kong F
    Biomed Pharmacother; 2024 Feb; 171():116113. PubMed ID: 38181717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breaching barriers in glioblastoma. Part II: Targeted drug delivery and lipid nanoparticles.
    Miranda A; Blanco-Prieto MJ; Sousa J; Pais A; Vitorino C
    Int J Pharm; 2017 Oct; 531(1):389-410. PubMed ID: 28801108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of Nanocarrier-Associated Approaches for Better Therapeutic Intervention in the Management of Glioblastoma.
    Vikram ; Kumar S; Ali J; Baboota S
    Assay Drug Dev Technol; 2024; 22(2):73-85. PubMed ID: 38193798
    [No Abstract]   [Full Text] [Related]  

  • 8. Unique roles of nanotechnology in medicine and cancer-II.
    Alam F; Naim M; Aziz M; Yadav N
    Indian J Cancer; 2015; 52(1):1-9. PubMed ID: 26837958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-Based Nanocarriers in the Treatment of Glioblastoma Multiforme (GBM): Challenges and Opportunities.
    Gupta T; Sahoo RK; Singh H; Katke S; Chaurasiya A; Gupta U
    AAPS PharmSciTech; 2023 Apr; 24(4):102. PubMed ID: 37041350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier.
    Wadhwa K; Chauhan P; Kumar S; Pahwa R; Verma R; Goyal R; Singh G; Sharma A; Rao N; Kaushik D
    Oncol Res; 2024; 32(5):877-897. PubMed ID: 38686045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near Infrared Fluorescent Nanoplatform for Targeted Intraoperative Resection and Chemotherapeutic Treatment of Glioblastoma.
    Reichel D; Sagong B; Teh J; Zhang Y; Wagner S; Wang H; Chung LWK; Butte P; Black KL; Yu JS; Perez JM
    ACS Nano; 2020 Jul; 14(7):8392-8408. PubMed ID: 32551496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new era of nanotechnology, an alternative to change cancer treatment.
    Jurj A; Braicu C; Pop LA; Tomuleasa C; Gherman CD; Berindan-Neagoe I
    Drug Des Devel Ther; 2017; 11():2871-2890. PubMed ID: 29033548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
    Karim R; Palazzo C; Evrard B; Piel G
    J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in the Use of Lipid-Based Nanoparticles Against Glioblastoma Multiforme.
    Ortega-Berlanga B; Gonzalez C; Navarro-Tovar G
    Arch Immunol Ther Exp (Warsz); 2021 Mar; 69(1):8. PubMed ID: 33772646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesicular systems employing natural substances as promising drug candidates for MMP inhibition in glioblastoma: A nanotechnological approach.
    Agarwal S; Muniyandi P; Maekawa T; Kumar DS
    Int J Pharm; 2018 Nov; 551(1-2):339-361. PubMed ID: 30236647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
    Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
    J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioblastoma multiforme: a glance at advanced therapies based on nanotechnology.
    Rezaei V; Rabiee A; Khademi F
    J Chemother; 2020 May; 32(3):107-117. PubMed ID: 31984871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A state-of-the-art liposome technology for glioblastoma treatment.
    Hasan I; Roy S; Ehexige E; Wu R; Chen Y; Gao Z; Guo B; Chang C
    Nanoscale; 2023 Nov; 15(45):18108-18138. PubMed ID: 37937394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-targeted Nano-architectures for Efficient Drug Delivery and Sensitization in Glioblastoma.
    Ravuluri JAV; Rao V; Kumar G; Manandhar S; Cheruku SP; Bisht P; Chamallmudi MR; Nandakumar K; Kumar L; Kumar N
    Curr Pharm Des; 2023; 29(22):1775-1790. PubMed ID: 37403389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Delivery Nanosystems in Glioblastoma Multiforme Treatment: Current State of the Art.
    Di Filippo LD; Duarte JL; Luiz MT; de Araújo JTC; Chorilli M
    Curr Neuropharmacol; 2021; 19(6):787-812. PubMed ID: 32867643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.